Please login to the form below

Not currently logged in
Email:
Password:

Takeda promotes Trevor Smith to CEO

Takeda Pharmaceuticals has appointed Trevor Smith as chief executive for Europe following the departure of Dr Erich Brunn

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe following the departure of Dr Erich Brunn.

Smith brings more than 30 years of pharmaceutical experience and a broad range of knowledge to the leadership role in Europe.

He has worked at Takeda for more than 10 years and served in various roles, including managing director of Takeda UK and vice president, new portfolio for Takeda Pharmaceuticals Europe.

Before joining Takeda, Smith served at Servier Laboratories as managing director of Servier South Africa and held the role in the UK. He also worked as the vice president of Northern Europe, based at the company's parent organisation in Paris, France.

Frank Morich, the company's head of international operations (Americas/Europe), said: "With Trevor's leadership and guidance, our European businesses will align their commercial strategies to ensure Takeda's continued growth and evolution in the region."

Smith replaces Dr Erich Brunn, who leaves Takeda. Brunn joined the company in 2001 as president of Takeda's operations in Germany.

21st April 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...